Drugs toxic to the bone marrow that target the stromal cells.

[1]  M. Boranić,et al.  [[Long-term bone marrow culture]. , 1998, Arhiv za higijenu rada i toksikologiju.

[2]  L. Gibson,et al.  Disruption of bone marrow stromal cell function by etoposide. , 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  H. Handa,et al.  Effects of vesnarinone on the bone marrow stromal cell-dependent proliferation and differentiation of HL60 cells in vitro. , 1997, Experimental hematology.

[4]  J. Kapeghian,et al.  Activation of CGS 12094 (prinomide metabolite) to 1,4-benzoquinone by myeloperoxidase: implications for human idiosyncratic agranulocytosis. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[5]  D. Ross.  Metabolic basis of benzene toxicity , 1996, European journal of haematology. Supplementum.

[6]  S. Hauser,et al.  Murine Marrow Stromal Response to Myelotoxic Agents in vitro , 1996, British journal of haematology.

[7]  R Snyder,et al.  An overview of benzene metabolism. , 1996, Environmental health perspectives.

[8]  L. Papadopoulou,et al.  Effects of hemin on apoptosis, suppression of cytochrome c oxidase gene expression, and bone-marrow toxicity induced by doxorubicin (adriamycin). , 1996, Biochemical pharmacology.

[9]  A. Sakai.  Diclofenac inhibits endothelial cell adhesion molecule expression induced with lipopolysaccharide. , 1996, Life sciences.

[10]  A. Keating,et al.  Biology of Bone Marrow Stroma , 1995, Annals of the New York Academy of Sciences.

[11]  A. Malkinson,et al.  Decreased content of the IL1 alpha processing enzyme calpain in murine bone marrow-derived macrophages after treatment with the benzene metabolite hydroquinone. , 1994, Toxicology letters.

[12]  T. Carlos,et al.  Leukocyte-endothelial adhesion molecules. , 1994, Blood.

[13]  N. Miyasaka,et al.  Gold sodium thiomalate down-regulates intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression on vascular endothelial cells. , 1994, Molecular pharmacology.

[14]  S. Hauser,et al.  Effects of ceftazidime, a betalactam antibiotic, on murine haemopoiesis in vitro , 1994, British journal of haematology.

[15]  M. Trush,et al.  Studies with 1,2-dithiole-3-thione as a chemoprotector of hydroquinone-induced toxicity to DBA/2-derived bone marrow stromal cells. , 1993, Environmental health perspectives.

[16]  B. Sredni,et al.  Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101). , 1993, Cancer research.

[17]  D. Ross,et al.  Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolites. , 1992, Molecular pharmacology.

[18]  B. Naughton,et al.  Differential Effects of Drugs upon Hematopoiesis Can Be Assessed in Long-Term Bone Marrow Cultures Established on Nylon Screens , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  J. Greenberger,et al.  The hematopoietic microenvironment. , 1991, Critical reviews in oncology/hematology.

[20]  E. Prens,et al.  Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers , 1990, Antimicrobial Agents and Chemotherapy.

[21]  D. Ross,et al.  Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. , 1990, Molecular pharmacology.

[22]  Y. Shimizu,et al.  T lymphocyte adhesion molecules. , 1989, The Year in immunology.

[23]  M J Reasor,et al.  Macrophage regulation of myelopoiesis is altered by exposure to the benzene metabolite hydroquinone. , 1989, Toxicology and applied pharmacology.

[24]  M. Gordon,et al.  Heparan sulfate is necessary for adhesive interactions between human early hemopoietic progenitor cells and the extracellular matrix of the marrow microenvironment. , 1988, Leukemia.

[25]  J. Falkenburg,et al.  Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by interleukin-1 and poly(rI).poly(rC). , 1988, Blood.

[26]  S. Tsai,et al.  Interleukin‐1 regulation of hematopoietic growth factor production by human stromal fibroblasts , 1988, Journal of cellular physiology.

[27]  P. Davis,et al.  Neutropenia occurring during the course of chrysotherapy: a review of 25 cases. , 1985, The Journal of rheumatology.

[28]  F. Ali-Osman,et al.  Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas. , 1985, Cancer research.

[29]  K. Neftel,et al.  Inhibition of Granulopoiesis in Vivo and in Vitro by β-Lactam Antibiotics , 1985 .

[30]  K. Gaido,et al.  In vitro effects of benzene metabolites on mouse bone marrow stromal cells. , 1984, Toxicology and applied pharmacology.

[31]  G. Eisenbrand,et al.  DNA damage and repair in the bone marrow of rats treated with four chloroethylnitrosoureas. , 1984, Cancer research.

[32]  P. Twomey,et al.  Toxicity of very high dose nitrosourea administration , 1982, Cancer.

[33]  J. Hickman,et al.  The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas. , 1982, Biochemical pharmacology.

[34]  R. Degowin,et al.  Residual injury to the hemopoietic microenvironment following sequential radiation and busulfan. , 1982, International journal of radiation oncology, biology, physics.

[35]  J. Fitchen,et al.  "Stromal" and hemopoietic stem cell abnormalities in long-term cultures of marrow from busulfan-treated mice. , 1982, Experimental hematology.

[36]  H. Hoagland.  Hematologic complications of cancer chemotherapy. , 1982, Seminars in oncology.

[37]  E. Cronkite,et al.  The detection of in vivo hematotoxicity of benzene by in vitro liquid bone marrow cultures. , 1981, Toxicology and applied pharmacology.

[38]  W. Fried,et al.  Residual marrow damage following therapy with cyclophosphamide. , 1980, Experimental hematology.

[39]  S. Sharkis,et al.  Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. , 1980, Blood.

[40]  W. Pratt,et al.  The Anticancer Drugs , 1979 .

[41]  W. Fried,et al.  Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma. , 1977, Cancer research.

[42]  A. Morley,et al.  An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan. , 1974, Blood.

[43]  A. Friedenstein,et al.  STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUES: Cloning In Vitro and Retransplantation In Vivo , 1974, Transplantation.

[44]  W. Crosby,et al.  Regeneration of locally irradiated bone marrow. II. Induction of regeneration in permanently aplastic medullary cavities. , 1968, Blood.

[45]  J. Trentin,et al.  HEMOPOIEITC SPLEEN COLONY STUDIES , 1967, The Journal of experimental medicine.

[46]  H. Handa,et al.  Possible involvement of bone marrow stromal cells in agranulocytosis caused by vesnarinone treatment. , 1997, Acta haematologica.

[47]  D. Williams,et al.  Matrix molecule interactions with hematopoietic stem cells. , 1995, Experimental hematology.

[48]  E. Deryugina,et al.  Stromal cells in long-term cultures: keys to the elucidation of hematopoietic development? , 1993, Critical reviews in immunology.

[49]  C. Chabannon,et al.  Stem cell-stromal cell interactions. , 1992, Current topics in microbiology and immunology.

[50]  D. Eastmond,et al.  Potential role of free radicals in benzene-induced myelotoxicity and leukemia. , 1991, Free radical biology & medicine.

[51]  D. Ross,et al.  Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma. , 1990, Free radical research communications.

[52]  K. Dorshkind,et al.  Regulation of hemopoiesis by bone marrow stromal cells and their products. , 1990, Annual review of immunology.

[53]  M. Schlosser,et al.  Metabolic activation of hydroquinone by macrophage peroxidase. , 1989, Chemico-biological interactions.

[54]  K. Udupa,et al.  Long-term bone marrow culture as a model for host toxicity: the effect of methotrexate on hematopoiesis and adherent layer function. , 1988, Experimental hematology.

[55]  P. Nikkels,et al.  Long-term effects of cytostatic agents on the hemopoietic stroma: a comparison of four different assays. , 1987, Leukemia research.

[56]  Montgomery Ja,et al.  Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems. , 1986 .

[57]  J. Hendry,et al.  Long-term damage to haemopoietic subpopulations in mice after repeated treatment with BCNU or cyclophosphamide. , 1986 .

[58]  J. Greenberger,et al.  The development of a system for study of bone marrow transplantation in vitro: effects of X-irradiation dose rate and chemotherapeutic agents on the isolated bone marrow microenvironment. , 1984, Kroc Foundation series.

[59]  R. Anderson,et al.  In vitro evaluation of hematopoiesis in mice treated with busulphan or nitrogen mustard. , 1982, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[60]  J. Greenberger,et al.  Effect of chemotherapy and irradiation on interactions between stromal and hemopoietic cells in vitro. , 1982, Scanning electron microscopy.

[61]  Ciucci Ag.  A review of spontaneously reported adverse drug reactions with diclofenac sodium (Voltarol). , 1979 .

[62]  Dunn Cd.  The chemical and biological properties of busulphan ("Myleran"). , 1974, Experimental hematology.